A third close contact of a patient in Missouri who was hospitalized with H5N1 bird flu has reported that they also experienced symptoms, the US Centers for Disease Control and Prevention said Friday.
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States since 2003.
Health officials identified three contacts, including two healthcare workers, who were closely monitored after a bird flu patient in Missouri was recently hospitalized.
Wisconsin Public Radio State health officials are warning Wisconsinites of a significant increase in cases of whooping cough. Data from ...
The local council has urged its citizens to 'be calm and cautious' as fears grow over the rapid spread of the virus.